Heron Therapeutics, Inc.

Direct answer

Heron Therapeutics, Inc. is publicly traded on NASDAQ under the ticker HRTX.

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from days to weeks following...

Can you invest in Heron Therapeutics, Inc.?

Yes. Heron Therapeutics, Inc. is publicly traded on NASDAQ under the ticker HRTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Heron Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.